El-Ashmawy, N. E., Khedr, N. F., El-Bahrawy, H. A., & Mansour, H. E. A. Metformin augments doxorubicin cytotoxicity in mammary carcinoma through activation of adenosine monophosphate protein kinase pathway. SAGE Publishing.
Chicago Style (17th ed.) CitationEl-Ashmawy, Nahla E., Naglaa F. Khedr, Hoda A. El-Bahrawy, and Hend E Abo Mansour. Metformin Augments Doxorubicin Cytotoxicity in Mammary Carcinoma Through Activation of Adenosine Monophosphate Protein Kinase Pathway. SAGE Publishing.
MLA (9th ed.) CitationEl-Ashmawy, Nahla E., et al. Metformin Augments Doxorubicin Cytotoxicity in Mammary Carcinoma Through Activation of Adenosine Monophosphate Protein Kinase Pathway. SAGE Publishing.
Warning: These citations may not always be 100% accurate.